ANIP

ANI Pharmaceuticals, Inc. [ANIP] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

ANIP Stock Summary

Top 10 Correlated ETFs

ANIP


Top 10 Correlated Stocks

ANIP


In the News

09:26 10 Dec 2023 ANIP

ANI Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference

BAUDETTE, Minn., Nov. 22, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President & CEO, will participate at the Piper Sandler 35th Annual Healthcare Conference in New York City as follows:

11:59 10 Dec 2023 ANIP

ANI Pharmaceuticals, Inc. (ANIP) Q3 2023 Earnings Call Transcript

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP ) Q3 2023 Earnings Conference Call November 8, 2023 8:30 AM ET Company Participants Judy DiClemente - Insight Communications IR Nikhil Lalwani - President and CEO Stephen Carey - CFO Conference Call Participants Les Sulewski - Truist Securities Vamil Divan - Guggenheim Securities Oren Livnat - H.C. Wainwright Operator Good day, everyone, and welcome to the ANI Pharmaceuticals, Inc. Third Quarter 2023 Earnings Results Call.

07:32 10 Dec 2023 ANIP

ANI Pharmaceuticals (ANIP) Stock Drops Despite Market Gains: Important Facts to Note

ANI Pharmaceuticals (ANIP) closed at $61.66 in the latest trading session, marking a -0.13% move from the prior day.

06:50 10 Dec 2023 ANIP

ANI Pharmaceuticals to Discuss Third Quarter 2023 Financial Results on November 8, 2023, at 8:30 a.m. ET

BAUDETTE, Minn., Oct. 25, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its third quarter 2023 financial results on Wednesday, November 8, 2023, prior to the market open.

07:33 10 Dec 2023 ANIP

ANI Pharmaceuticals (ANIP) Increases Despite Market Slip: Here's What You Need to Know

ANI Pharmaceuticals (ANIP) closed at $57.44 in the latest trading session, marking a +0.23% move from the prior day.

07:32 10 Dec 2023 ANIP

ANI Pharmaceuticals (ANIP) Stock Sinks As Market Gains: Here's Why

The latest trading day saw ANI Pharmaceuticals (ANIP) settling at $58.39, representing a -0.41% change from its previous close.

04:05 10 Dec 2023 ANIP

ANI Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023

BAUDETTE, Minn., Sept. 18, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the Cantor Global Healthcare Conference 2023 in New York City as follows:

03:47 10 Dec 2023 ANIP

Here's Why You Should Add ANI Pharmaceuticals (ANIP) to Your Portfolio

ANI Pharmaceuticals (ANIP), a top-ranked stock, has a diverse portfolio of rare disease and generic medicines. Its Purified Cortrophin Gel is witnessing incremental sales in recent quarters.

10:32 10 Dec 2023 ANIP

ANI (ANIP) Is a Great Choice for 'Trend' Investors, Here's Why

If you are looking for stocks that are well positioned to maintain their recent uptrend, ANI (ANIP) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

01:32 10 Dec 2023 ANIP

What Makes ANI (ANIP) a New Strong Buy Stock

ANI (ANIP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

ANIP Financial details

Company Rating
Buy
Market Cap
999.68M
Income
13.38M
Revenue
449.39M
Book val./share
24.08
Cash/share
10.22
Dividend
-
Dividend %
-
Employees
600
Optionable
No
Shortable
Yes
Earnings
08 Nov 2023
P/E
69.06
Forward P/E
12.3
PEG
-5.92
P/S
2.22
P/B
2.03
P/C
4.79
P/FCF
18.88
Quick Ratio
2.77
Current Ratio
3.7
Debt / Equity
0.63
LT Debt / Equity
0.63
-
-
EPS (TTM)
0.56
EPS next Y
3.98
EPS next Q
0.84
EPS this Y
-12.72%
EPS next Y
610.71%
EPS next 5Y
282.14%
EPS last 5Y
NAN%
Revenue last 5Y
9.43%
Revenue Q/Q
13.11%
EPS Q/Q
53.33%
-
-
-
-
SMA20
-16.82%
SMA50
-16.32%
SMA100
-3.13%
Inst Own
56.78%
Inst Trans
0.76%
ROA
2%
ROE
3%
ROC
0.06%
Gross Margin
63%
Oper. Margin
10%
Profit Margin
3%
Payout
12%
Shs Outstand
20.43M
Shs Float
16.12M
-
-
-
-
Target Price
48
52W Range
36.54-65.89
52W High
-24.71%
52W Low
+35.94%
RSI
33.38
Rel Volume
1.23
Avg Volume
167.31K
Volume
205.17K
Perf Week
-0.66%
Perf Month
-19.08%
Perf Quarter
-7.08%
Perf Half Y
-0.93%
-
-
-
-
Beta
0.885
-
-
Volatility
0.68%, 5.16%
Prev Close
0.43%
Price
48.94
Change
0.2%

ANIP Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
17.2617.4417.4317.1619.46
Net income per share
1.330.51-1.88-3.38-2.95
Operating cash flow per share
5.743.851.280.26-1.92
Free cash flow per share
4.811.53-4.43-1.61-2.93
Cash per share
3.685.260.667.962.97
Book value per share
16.8917.9716.3628.4820.82
Tangible book value per share
-0.682.430.32.923.61
Share holders equity per share
16.8917.9716.3628.4820.82
Interest debt per share
16.9416.7816.3123.7619.35
Market cap
525.7M730.23M347.43M580.42M654.14M
Enterprise value
665.71M853.65M525.26M767.49M892.43M
P/E ratio
33.93119.83-15.41-13.62-13.66
Price to sales ratio
2.613.541.672.692.07
POCF ratio
7.841622.76174.72-20.96
PFCF ratio
9.3640.38-6.55-28.57-13.73
P/B Ratio
2.663.431.781.621.93
PTB ratio
2.663.431.781.621.93
EV to sales
3.34.132.523.552.82
Enterprise value over EBITDA
9.7114.0418.3852.0727.97
EV to operating cash flow
9.9218.7134.4231.03-28.6
EV to free cash flow
11.8547.21-9.9-37.78-18.73
Earnings yield
0.030.01-0.06-0.07-0.07
Free cash flow yield
0.110.02-0.15-0.04-0.07
Debt to equity
0.930.870.950.80.85
Debt to assets
0.430.410.40.370.38
Net debt to EBITDA
2.042.036.2212.697.47
Current ratio
0.923.042.173.683.46
Interest coverage
2.41.26-1.7-2.73-0.89
Income quality
4.337.49-0.68-0.080.65
Dividend Yield
00000
Payout ratio
0000-0.03
Sales general and administrative to revenue
0.220000
Research and developement to revenue
0.080.10.080.050.07
Intangibles to total assets
0.480.40.420.420.37
Capex to operating cash flow
-0.16-0.6-4.48-7.120.53
Capex to revenue
-0.05-0.13-0.33-0.11-0.05
Capex to depreciation
-0.32-0.62-1.53-0.5-0.28
Stock based compensation to revenue
0.030.040.060.050.05
Graham number
22.4614.4326.3446.5637.15
ROIC
0.070.08-0.04-0.04-0.03
Return on tangible assets
0.070.02-0.08-0.09-0.1
Graham Net
-10.4-8.74-12.99-13.92-12.09
Working capital
-12.67M126.02M91.76M234.24M244.82M
Tangible asset value
-7.92M28.82M3.61M36.73M58.68M
Net current asset value
-80.46M-56.3M-95.17M-91.08M-77.29M
Invested capital
0.930.870.950.80.85
Average receivables
61.82M68.49M83.96M112.16M146.98M
Average payables
6.26M11.75M12.93M17.11M26.14M
Average inventory
39.12M44.33M54.48M71.25M93.52M
Days sales outstanding
117.41127.46167.72217.05190.86
Days payables outstanding
44.4184.4247.1683.3277.07
Days of inventory on hand
202.45278.36254.63296.37277.08
Receivables turnover
3.112.862.181.681.91
Payables turnover
8.224.327.744.384.74
Inventory turnover
1.81.311.431.231.32
ROE
0.080.03-0.12-0.12-0.14
Capex per share
-0.93-2.33-5.71-1.88-1.01

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
5.145.776.516.596.98
Net income per share
-0.53-0.260.090.350.53
Operating cash flow per share
0.22-0.271.311.171.7
Free cash flow per share
-0.38-0.461.160.781.46
Cash per share
3.452.954.139.1410.22
Book value per share
20.6520.7420.7124.5624.08
Tangible book value per share
2.713.594.429.9510.94
Share holders equity per share
20.6520.7420.7124.5624.08
Interest debt per share
18.0318.0117.9416.5815.48
Market cap
523.98M656.75M651.09M952.15M1.1B
Enterprise value
754.43M895.05M869.64M1.08B1.19B
P/E ratio
-15.23-38.7113.1238.1227.57
Price to sales ratio
6.256.976.18.178.32
POCF ratio
144.63-149.2630.3946.1634.08
PFCF ratio
-84.64-87.0834.146939.7
P/B Ratio
1.561.941.922.192.41
PTB ratio
1.561.941.922.192.41
EV to sales
99.58.149.249.02
Enterprise value over EBITDA
52.3646.0132.6338.3438.91
EV to operating cash flow
208.23-203.4240.5952.1936.97
EV to free cash flow
-121.86-118.6745.678.0143.06
Earnings yield
-0.02-0.0100.010.01
Free cash flow yield
-0.01-0.010.030.010.03
Debt to equity
0.850.850.840.660.63
Debt to assets
0.390.380.370.330.32
Net debt to EBITDA
15.9912.258.24.433.04
Current ratio
3.793.462.93.743.7
Interest coverage
-0.130.661.291.752.81
Income quality
-0.421.0414.893.33.24
Dividend Yield
00000
Payout ratio
-0.05-0.10.280.070.04
Sales general and administrative to revenue
00000
Research and developement to revenue
0.090.060.060.060.08
Intangibles to total assets
0.40.370.350.30.28
Capex to operating cash flow
-2.710.71-0.11-0.33-0.14
Capex to revenue
-0.12-0.03-0.02-0.06-0.03
Capex to depreciation
-0.64-0.2-0.16-0.46-0.3
Stock based compensation to revenue
0.050.040.040.050.04
Graham number
15.6611.016.413.9716.89
ROIC
00.010.010.020.02
Return on tangible assets
-0.02-0.0100.010.02
Graham Net
-11.83-12.04-10.68-4.6-2.9
Working capital
227.75M244.82M238.93M336.45M362.87M
Tangible asset value
44.22M58.68M72.47M175.95M206.66M
Net current asset value
-93.06M-77.29M-60.99M34.44M62.02M
Invested capital
0.850.850.840.660.63
Average receivables
145.42M152.94M170.08M173.82M175.88M
Average payables
23.32M24.15M31M30.6M31.29M
Average inventory
94.22M100.62M104.5M103.99M105.46M
Days sales outstanding
150.79158.01147.25133.54122.1
Days payables outstanding
51.9672.6178.0260.6763.76
Days of inventory on hand
262.37261.02247.4222.05199.44
Receivables turnover
0.60.570.610.670.74
Payables turnover
1.731.241.151.481.41
Inventory turnover
0.340.340.360.410.45
ROE
-0.03-0.0100.010.02
Capex per share
-0.6-0.19-0.14-0.39-0.24

ANIP Frequently Asked Questions

What is ANI Pharmaceuticals, Inc. stock symbol ?

ANI Pharmaceuticals, Inc. is a US stock , located in Baudette of Mn and trading under the symbol ANIP

Is ANI Pharmaceuticals, Inc. buy or a sell ?

1 stock analysts have 1 predictions with a medium analyst target price of $48. The lowest prediction is $48 and the highest is $48

What is ANIP stock prediction ?

What is ANI Pharmaceuticals, Inc. stock quote today ?

ANI Pharmaceuticals, Inc. stock price is $48.94 today.

Is ANI Pharmaceuticals, Inc. stock public?

Yes, ANI Pharmaceuticals, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap